Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sony DADC is a global leader in high-precision manufacturing and supply chain solutions, originally established as the optical disc manufacturing arm of the Sony Group. In the life sciences sector, the company became a pioneer in the mass production of polymer-based microfluidic consumables, leveraging its expertise in nano-structuring and injection molding. While its dedicated BioSciences division was acquired by STRATEC SE in 2016 and rebranded as STRATEC Consumables, Sony DADC's legacy in the field remains significant as a foundational developer of smart consumables for diagnostics. The company continues to operate as a major subsidiary of Sony, focusing on entertainment media and advanced manufacturing services. Its contributions to healthcare primarily involve the transition of complex diagnostic prototypes into high-volume, medical-grade commercial products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sony DADC.